 The CEOs, Hoda Tawfik and Christian von Volkmann, re-evaluated the company's strategy, and raised 33.3 million euros, and used about half of that to retire debt.Around that time they hired Ben J. Lipps, former chairman of Fresenius Medical Care, to become CEO.The company established a US subsidiary, which raised around $15M in 2014 to pursue US approval.